Wolfram syndrome 1 (WS) |
|
Total GSH |
Wfs1−/− mice |
[44] |
Wolfram syndrome |
|
GSSG/GSH and NAD(+)/NADH ratios |
Miner1(−/−) mice |
[45] |
Age-related macular degeneration (AMD) |
|
Plasma Total GSH |
Human AMD patients |
[46] |
Exudative AMD |
|
Plasma Total GSH |
Human ex-AMD patients |
[47] |
Exudative AMD |
|
Plasma Total GSH |
Human ex-AMD patients |
[48] |
AMD |
|
Mitochondrial GSH |
hRPE cells and RPE from alpha Cry KO mice |
[49] |
AMD |
|
Cellular GSH |
ARPE-19 cells treated with BSO or erastin |
[50] |
AMD |
|
Oxidized glutathione (GSSG) in plasma |
Human early AMD patients |
[24] |
Dry AMD |
|
Total GSH |
RPE cells from AMD donors subjected to H2O2 |
[51] |
AMD |
N-acetylcysteine (precursor for GSH) improved maximal respiration and ATP production |
RPE cells from AMD donors |
[52] |
AMD |
|
Cellular GSH, ATP production, and basal respiration |
RPE from AMD donors and non-AMD with and without H2O2 treatment |
[21] |
AMD |
|
GSH:GSSG ratio |
ARPE19 cells subjected to H2O2 exposure |
[53] |
AMD |
|
Ocular GSH |
ARPE 19 incubated with and rats fed N-acetyl-L-cysteine ethyl ester or N-acetyl-L-cysteine |
[54] |
AMD |
|
GSH |
LAMP2-silenced ARPE-19 cells. |
[55] |
AMD |
|
GSH |
ARPE19 cells stressed with tert-Butyl hydroperoxide |
[56] |
AMD |
|
GSH |
ARPE-19/primary human RPE cells were exposed to cigarette smoke extract or hydroquinone |
[57] |
AMD |
|
GSH |
ARPE-19 cells treated with H2O2 |
[58] |
AMD |
|
Cellular GSH |
ARPE-19 cells treated with hydroquinone |
[59] |
AMD |
|
Cellular and mitoGSH |
ARPE-19 treated with NAC prodrugs |
[59] |
AMD |
|
GSH |
ARPE-19 cells treated with H2O2 |
[60] |
Diabetic retinopathy |
|
MitoGSH |
Streptozotocin (STZ) diabetic mice |
[61] |
Diabetic retinopathy |
|
Retinal GSH |
STZ-injected Nrf2−/− mice |
[62] |
Diabetic retinopathy |
|
GSH |
STZ rats |
[63] |
Glaucoma |
|
Plasma GSH levels |
Human glaucoma patients |
[64] |
Glaucoma |
|
GSSG levels |
Human peripheral blood mononuclear cells |
[65] |
Glaucoma |
|
Plasma GSH |
Human blood |
[22] |
Retinitis pigmentosa |
|
Increased GSH |
rd1(+/+) and rd10(+/+) mice treated with NAC |
[66] |
Retinitis pigmentosa |
|
GSSG level |
rd10 mouse model |
[67] |